Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Flexible ECG Patch Enables Arrhythmia Detection

By HospiMedica staff writers
Posted on 05 Aug 2008
An innovative electrocardiogram (ECG) patch monitors single-lead ECG in daily-life conditions, opening new perspectives for cardiovascular disease management.

The IMEC wireless ECG patch is a wearable, wire-free hybrid system that combines electronic assembly on flexible polyimide substrate and integration in textile. More...
This enables flexibility in one dimension and stretchability in the other, required for optimal personal comfort. The patch features a proprietary ultra-low-power bio-potential application specific integrated circuit (ASIC) to extract the bio-potential signals produced during the ECG measurements, a commercial microcontroller, and a 2.4 GHz radio link.

The patch can continuously monitor the patient's heart at a sample rate of up to 1 kHz; it sends the results directly to the receiver, or it can analyze the signals locally before sending them by using an algorithm embedded in the system that performs delineation of the ECG signal (the detection of the important electrical waves from the heart). The delineator algorithm achieves excellent results for both sensitivity and predictivity, and covers a broad range of wave morphologies by identifying P, Q, R, S, and T wave peaks and boundaries; since the intervals and amplitudes of these waves contain most of the useful information of the ECG, the delineation provides quick and useful information to the healthcare provider. An additional benefit of the local analysis is the reduction of radio usage, improving the autonomy of the patch; current autonomy with local delineation is 10 days of continuous monitoring. The wireless ECG patch is under development by the Human++ program team at the Interuniversity Microelectronics Center (Leuven, Belgium).

"Our physiological monitoring systems are based on ultra-low power wireless communication and start to make use of innovative energy harvesting technology,” said Bert Gyselinckx, Human++ program director. "They are finding applications in sleep staging analysis, cardiac arrhythmia detection and epilepsy monitoring. The growing interest from industry worldwide is proven by new partnerships.”

The IMEC Human++ program develops technology for wireless autonomous sensor systems that can be used for health and wellness monitoring. Such systems will for example enable analysis of people with sleep apnea from home or monitor epilepsy patients in an ambulatory setting. The program was launched in 2002. National Semiconductor recently joined the Human++ program, joining other partners at the IMEC Holst Center (Eindhoven; The Netherlands) such as Alcatel-Lucent, ASML, Bekaert, NXP, Philips, Target Compiler Technologies, and Texas Instruments.


Related Links:
IMEC Holst Center
Interuniversity Microelectronics Center

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.